SCHEMBL24460486

SCHEMBL24460486

Cc1cc2ncc(C)n2cc1-c1ccc(OC(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.41
CYP1A2 P05177 1/20 0.41
ACACB O00763 2/20 0.38
ACACA Q13085 2/20 0.38
WDR5 P61964 1/20 0.37
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
CLK1 P49759 1/20 0.36
BTK Q06187 1/20 0.36
TGFBR1 P36897 1/20 0.36
BMPR1B O00238 1/20 0.34
ACVR1B P36896 1/20 0.34
ACVRL1 P37023 1/20 0.34
ACVR1 Q04771 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34
FLT3 P36888 1/20 0.34
PIK3CA P42336 1/20 0.33
MTOR P42345 1/20 0.33
MCL1 Q07820 2/20 0.33
EGLN1 Q9GZT9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19781160 0.88 FLT3 (0.43) MAP4K4CYP1A2ACACBACACAWDR5
SCHEMBL24460364 0.87 MAP4K4 (0.40) MAP4K4CYP1A2ACACBACACAWDR5
SCHEMBL24460388 0.85 PDE10A (0.42) TGFBR1FLT3PIK3CAMTOR
SCHEMBL24460211 0.82 KDR (0.40) MAP4K4CYP1A2ACACBACACABMPR1B
SCHEMBL24460309 0.82 ALOX5AP (0.39) MAPTTGFBR1FFAR4
SCHEMBL24460242 0.81 PIK3CA (0.39) MAP4K4CYP1A2ACACBACACAWDR5
SCHEMBL24460254 0.81 RIPK2 (0.41) MAP4K4CYP1A2ACACBACACAFLT3
SCHEMBL22071837 0.81 RIPK2 (0.41) MAP4K4CYP1A2ACACBACACACLK1
SCHEMBL24460264 0.81 RIPK2 (0.41) MAP4K4CYP1A2ACACBACACAFLT3
SCHEMBL24460399 0.81 CLK1 (0.47) MAP4K4CYP1A2WDR5TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022108849-A1 HETEROCYCLIC COMPOUNDS AS THERAPEUTIC AGENTS ARISAN THERAPEUTICS INC. (US) 2022-05-27 WO disclosed